 | • レポートコード：GIR-107A15065 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、女性健康用医薬品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。女性健康用医薬品の種類別市場規模（顆粒、丸薬、粉末、チンキ剤、錠剤、カプセル、その他）、用途別市場規模（閉経後骨粗鬆症、子宮内膜症、多嚢胞性卵巣症候群、妊娠障害、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・女性健康用医薬品の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Allergan、Lilly、Pfizer、Bayer、AbbVie、Amgen、Johnson＆Johnson ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：顆粒、丸薬、粉末、チンキ剤、錠剤、カプセル、その他 ・用途別分析2016年-2026年：閉経後骨粗鬆症、子宮内膜症、多嚢胞性卵巣症候群、妊娠障害、その他 ・女性健康用医薬品の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・女性健康用医薬品のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・女性健康用医薬品のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・女性健康用医薬品の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・女性健康用医薬品の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Pharmaceuticals for Women’s Health market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pharmaceuticals for Women’s Health size is estimated to be USD 29480 million in 2026 from USD 26920 million in 2020, with a change XX% between 2020 and 2021. The global Pharmaceuticals for Women’s Health market size is expected to grow at a CAGR of 2.3% for the next five years.
Market segmentation
Pharmaceuticals for Women’s Health market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Granules
Pills
Powder
Tincture
Tablets
Capsule
Other
Market segment by Application, can be divided into
Postmenopausal Osteoporosis
Endometriosis
Polycystic Ovarian Syndrome
Pregnancy Disorders
Others
Market segment by players, this report covers
Allergan
Lilly
Pfizer
Bayer
AbbVie
Amgen
Johnson＆Johnson
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Pharmaceuticals for Women’s Health
1.2 Classification of Pharmaceuticals for Women’s Health by Type
1.2.1 Overview: Global Pharmaceuticals for Women’s Health Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Pharmaceuticals for Women’s Health Revenue Market Share by Type in 2020
1.2.3 Granules
1.2.4 Pills
1.2.5 Powder
1.2.6 Tincture
1.2.7 Tablets
1.2.8 Capsule
1.2.9 Other
1.3 Global Pharmaceuticals for Women’s Health Market by Application
1.3.1 Overview: Global Pharmaceuticals for Women’s Health Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Postmenopausal Osteoporosis
1.3.3 Endometriosis
1.3.4 Polycystic Ovarian Syndrome
1.3.5 Pregnancy Disorders
1.3.6 Others
1.4 Global Pharmaceuticals for Women’s Health Market Size & Forecast
1.5 Global Pharmaceuticals for Women’s Health Market Size and Forecast by Region
1.5.1 Global Pharmaceuticals for Women’s Health Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Pharmaceuticals for Women’s Health Market Size by Region, (2016-2021)
1.5.3 North America Pharmaceuticals for Women’s Health Market Size and Prospect (2016-2026)
1.5.4 Europe Pharmaceuticals for Women’s Health Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Pharmaceuticals for Women’s Health Market Size and Prospect (2016-2026)
1.5.6 South America Pharmaceuticals for Women’s Health Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Pharmaceuticals for Women’s Health Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Pharmaceuticals for Women’s Health Market Drivers
1.6.2 Pharmaceuticals for Women’s Health Market Restraints
1.6.3 Pharmaceuticals for Women’s Health Trends Analysis
2 Company Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business
2.1.3 Allergan Pharmaceuticals for Women’s Health Product and Solutions
2.1.4 Allergan Pharmaceuticals for Women’s Health Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Allergan Recent Developments and Future Plans
2.2 Lilly
2.2.1 Lilly Details
2.2.2 Lilly Major Business
2.2.3 Lilly Pharmaceuticals for Women’s Health Product and Solutions
2.2.4 Lilly Pharmaceuticals for Women’s Health Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Lilly Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Pharmaceuticals for Women’s Health Product and Solutions
2.3.4 Pfizer Pharmaceuticals for Women’s Health Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Pharmaceuticals for Women’s Health Product and Solutions
2.4.4 Bayer Pharmaceuticals for Women’s Health Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bayer Recent Developments and Future Plans
2.5 AbbVie
2.5.1 AbbVie Details
2.5.2 AbbVie Major Business
2.5.3 AbbVie Pharmaceuticals for Women’s Health Product and Solutions
2.5.4 AbbVie Pharmaceuticals for Women’s Health Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 AbbVie Recent Developments and Future Plans
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Pharmaceuticals for Women’s Health Product and Solutions
2.6.4 Amgen Pharmaceuticals for Women’s Health Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Amgen Recent Developments and Future Plans
2.7 Johnson＆Johnson
2.7.1 Johnson＆Johnson Details
2.7.2 Johnson＆Johnson Major Business
2.7.3 Johnson＆Johnson Pharmaceuticals for Women’s Health Product and Solutions
2.7.4 Johnson＆Johnson Pharmaceuticals for Women’s Health Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Johnson＆Johnson Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pharmaceuticals for Women’s Health Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Pharmaceuticals for Women’s Health Players Market Share
3.2.2 Top 10 Pharmaceuticals for Women’s Health Players Market Share
3.2.3 Market Competition Trend
3.3 Pharmaceuticals for Women’s Health Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Pharmaceuticals for Women’s Health Revenue and Market Share by Type (2016-2021)
4.2 Global Pharmaceuticals for Women’s Health Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Pharmaceuticals for Women’s Health Revenue Market Share by Application (2016-2021)
5.2 Pharmaceuticals for Women’s Health Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Pharmaceuticals for Women’s Health Revenue by Type (2016-2026)
6.2 North America Pharmaceuticals for Women’s Health Revenue by Application (2016-2026)
6.3 North America Pharmaceuticals for Women’s Health Market Size by Country
6.3.1 North America Pharmaceuticals for Women’s Health Revenue by Country (2016-2026)
6.3.2 United States Pharmaceuticals for Women’s Health Market Size and Forecast (2016-2026)
6.3.3 Canada Pharmaceuticals for Women’s Health Market Size and Forecast (2016-2026)
6.3.4 Mexico Pharmaceuticals for Women’s Health Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Pharmaceuticals for Women’s Health Revenue by Type (2016-2026)
7.2 Europe Pharmaceuticals for Women’s Health Revenue by Application (2016-2026)
7.3 Europe Pharmaceuticals for Women’s Health Market Size by Country
7.3.1 Europe Pharmaceuticals for Women’s Health Revenue by Country (2016-2026)
7.3.2 Germany Pharmaceuticals for Women’s Health Market Size and Forecast (2016-2026)
7.3.3 France Pharmaceuticals for Women’s Health Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Pharmaceuticals for Women’s Health Market Size and Forecast (2016-2026)
7.3.5 Russia Pharmaceuticals for Women’s Health Market Size and Forecast (2016-2026)
7.3.6 Italy Pharmaceuticals for Women’s Health Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Pharmaceuticals for Women’s Health Revenue by Type (2016-2026)
8.2 Asia-Pacific Pharmaceuticals for Women’s Health Revenue by Application (2016-2026)
8.3 Asia-Pacific Pharmaceuticals for Women’s Health Market Size by Region
8.3.1 Asia-Pacific Pharmaceuticals for Women’s Health Revenue by Region (2016-2026)
8.3.2 China Pharmaceuticals for Women’s Health Market Size and Forecast (2016-2026)
8.3.3 Japan Pharmaceuticals for Women’s Health Market Size and Forecast (2016-2026)
8.3.4 South Korea Pharmaceuticals for Women’s Health Market Size and Forecast (2016-2026)
8.3.5 India Pharmaceuticals for Women’s Health Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Pharmaceuticals for Women’s Health Market Size and Forecast (2016-2026)
8.3.7 Australia Pharmaceuticals for Women’s Health Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Pharmaceuticals for Women’s Health Revenue by Type (2016-2026)
9.2 South America Pharmaceuticals for Women’s Health Revenue by Application (2016-2026)
9.3 South America Pharmaceuticals for Women’s Health Market Size by Country
9.3.1 South America Pharmaceuticals for Women’s Health Revenue by Country (2016-2026)
9.3.2 Brazil Pharmaceuticals for Women’s Health Market Size and Forecast (2016-2026)
9.3.3 Argentina Pharmaceuticals for Women’s Health Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Pharmaceuticals for Women’s Health Revenue by Type (2016-2026)
10.2 Middle East & Africa Pharmaceuticals for Women’s Health Revenue by Application (2016-2026)
10.3 Middle East & Africa Pharmaceuticals for Women’s Health Market Size by Country
10.3.1 Middle East & Africa Pharmaceuticals for Women’s Health Revenue by Country (2016-2026)
10.3.2 Turkey Pharmaceuticals for Women’s Health Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Pharmaceuticals for Women’s Health Market Size and Forecast (2016-2026)
10.3.4 UAE Pharmaceuticals for Women’s Health Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Pharmaceuticals for Women's Health Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Pharmaceuticals for Women's Health Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Pharmaceuticals for Women's Health Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Pharmaceuticals for Women's Health Revenue (USD Million) by Region (2016-2021)
Table 5. Global Pharmaceuticals for Women's Health Revenue Market Share by Region (2021-2026)
Table 6. Allergan Corporate Information, Head Office, and Major Competitors
Table 7. Allergan Major Business
Table 8. Allergan Pharmaceuticals for Women's Health Product and Solutions
Table 9. Allergan Pharmaceuticals for Women's Health Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Lilly Corporate Information, Head Office, and Major Competitors
Table 11. Lilly Major Business
Table 12. Lilly Pharmaceuticals for Women's Health Product and Solutions
Table 13. Lilly Pharmaceuticals for Women's Health Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Pfizer Corporate Information, Head Office, and Major Competitors
Table 15. Pfizer Major Business
Table 16. Pfizer Pharmaceuticals for Women's Health Product and Solutions
Table 17. Pfizer Pharmaceuticals for Women's Health Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bayer Corporate Information, Head Office, and Major Competitors
Table 19. Bayer Major Business
Table 20. Bayer Pharmaceuticals for Women's Health Product and Solutions
Table 21. Bayer Pharmaceuticals for Women's Health Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. AbbVie Corporate Information, Head Office, and Major Competitors
Table 23. AbbVie Major Business
Table 24. AbbVie Pharmaceuticals for Women's Health Product and Solutions
Table 25. AbbVie Pharmaceuticals for Women's Health Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Amgen Corporate Information, Head Office, and Major Competitors
Table 27. Amgen Major Business
Table 28. Amgen Pharmaceuticals for Women's Health Product and Solutions
Table 29. Amgen Pharmaceuticals for Women's Health Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Johnson＆Johnson Corporate Information, Head Office, and Major Competitors
Table 31. Johnson＆Johnson Major Business
Table 32. Johnson＆Johnson Pharmaceuticals for Women's Health Product and Solutions
Table 33. Johnson＆Johnson Pharmaceuticals for Women's Health Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Pharmaceuticals for Women's Health Revenue (USD Million) by Players (2019-2021)
Table 35. Global Pharmaceuticals for Women's Health Revenue Share by Players (2019-2021)
Table 36. Breakdown of Pharmaceuticals for Women's Health by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Pharmaceuticals for Women's Health Players Head Office, Products and Services Provided
Table 38. Pharmaceuticals for Women's Health Mergers & Acquisitions in the Past Five Years
Table 39. Pharmaceuticals for Women's Health New Entrants and Expansion Plans
Table 40. Global Pharmaceuticals for Women's Health Revenue (USD Million) by Type (2016-2021)
Table 41. Global Pharmaceuticals for Women's Health Revenue Share by Type (2016-2021)
Table 42. Global Pharmaceuticals for Women's Health Revenue Forecast by Type (2021-2026)
Table 43. Global Pharmaceuticals for Women's Health Revenue by Application (2016-2021)
Table 44. Global Pharmaceuticals for Women's Health Revenue Forecast by Application (2021-2026)
Table 45. North America Pharmaceuticals for Women's Health Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Pharmaceuticals for Women's Health Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Pharmaceuticals for Women's Health Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Pharmaceuticals for Women's Health Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Pharmaceuticals for Women's Health Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Pharmaceuticals for Women's Health Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Pharmaceuticals for Women's Health Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Pharmaceuticals for Women's Health Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Pharmaceuticals for Women's Health Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Pharmaceuticals for Women's Health Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Pharmaceuticals for Women's Health Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Pharmaceuticals for Women's Health Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Pharmaceuticals for Women's Health Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Pharmaceuticals for Women's Health Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Pharmaceuticals for Women's Health Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Pharmaceuticals for Women's Health Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Pharmaceuticals for Women's Health Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Pharmaceuticals for Women's Health Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Pharmaceuticals for Women's Health Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Pharmaceuticals for Women's Health Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Pharmaceuticals for Women's Health Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Pharmaceuticals for Women's Health Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Pharmaceuticals for Women's Health Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Pharmaceuticals for Women's Health Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Pharmaceuticals for Women's Health Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Pharmaceuticals for Women's Health Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Pharmaceuticals for Women's Health Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Pharmaceuticals for Women's Health Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Pharmaceuticals for Women's Health Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Pharmaceuticals for Women's Health Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Pharmaceuticals for Women's Health Picture
Figure 2. Global Pharmaceuticals for Women's Health Revenue Market Share by Type in 2020
Figure 3. Granules
Figure 4. Pills
Figure 5. Powder
Figure 6. Tincture
Figure 7. Tablets
Figure 8. Capsule
Figure 9. Other
Figure 10. Pharmaceuticals for Women's Health Revenue Market Share by Application in 2020
Figure 11. Postmenopausal Osteoporosis Picture
Figure 12. Endometriosis Picture
Figure 13. Polycystic Ovarian Syndrome Picture
Figure 14. Pregnancy Disorders Picture
Figure 15. Others Picture
Figure 16. Global Pharmaceuticals for Women's Health Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 17. Global Pharmaceuticals for Women's Health Revenue and Forecast (2016-2026) & (USD Million)
Figure 18. Global Pharmaceuticals for Women's Health Revenue Market Share by Region (2016-2026)
Figure 19. Global Pharmaceuticals for Women's Health Revenue Market Share by Region in 2020
Figure 20. North America Pharmaceuticals for Women's Health Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Europe Pharmaceuticals for Women's Health Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Asia-Pacific Pharmaceuticals for Women's Health Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. South America Pharmaceuticals for Women's Health Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. Middle East and Africa Pharmaceuticals for Women's Health Revenue (USD Million) and Growth Rate (2016-2026)
Figure 25. Pharmaceuticals for Women's Health Market Drivers
Figure 26. Pharmaceuticals for Women's Health Market Restraints
Figure 27. Pharmaceuticals for Women's Health Market Trends
Figure 28. Allergan Recent Developments and Future Plans
Figure 29. Lilly Recent Developments and Future Plans
Figure 30. Pfizer Recent Developments and Future Plans
Figure 31. Bayer Recent Developments and Future Plans
Figure 32. AbbVie Recent Developments and Future Plans
Figure 33. Amgen Recent Developments and Future Plans
Figure 34. Johnson＆Johnson Recent Developments and Future Plans
Figure 35. Global Pharmaceuticals for Women's Health Revenue Share by Players in 2020
Figure 36. Pharmaceuticals for Women's Health Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players Pharmaceuticals for Women's Health Revenue Market Share in 2020
Figure 38. Global Top 10 Players Pharmaceuticals for Women's Health Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global Pharmaceuticals for Women's Health Revenue Share by Type in 2020
Figure 41. Global Pharmaceuticals for Women's Health Market Share Forecast by Type (2021-2026)
Figure 42. Global Pharmaceuticals for Women's Health Revenue Share by Application in 2020
Figure 43. Global Pharmaceuticals for Women's Health Market Share Forecast by Application (2021-2026)
Figure 44. North America Pharmaceuticals for Women's Health Sales Market Share by Type (2016-2026)
Figure 45. North America Pharmaceuticals for Women's Health Sales Market Share by Application (2016-2026)
Figure 46. North America Pharmaceuticals for Women's Health Revenue Market Share by Country (2016-2026)
Figure 47. United States Pharmaceuticals for Women's Health Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Pharmaceuticals for Women's Health Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Pharmaceuticals for Women's Health Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Pharmaceuticals for Women's Health Sales Market Share by Type (2016-2026)
Figure 51. Europe Pharmaceuticals for Women's Health Sales Market Share by Application (2016-2026)
Figure 52. Europe Pharmaceuticals for Women's Health Revenue Market Share by Country (2016-2026)
Figure 53. Germany Pharmaceuticals for Women's Health Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Pharmaceuticals for Women's Health Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Pharmaceuticals for Women's Health Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Pharmaceuticals for Women's Health Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Pharmaceuticals for Women's Health Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Pharmaceuticals for Women's Health Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific Pharmaceuticals for Women's Health Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Pharmaceuticals for Women's Health Revenue Market Share by Region (2016-2026)
Figure 61. China Pharmaceuticals for Women's Health Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Pharmaceuticals for Women's Health Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea Pharmaceuticals for Women's Health Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Pharmaceuticals for Women's Health Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Pharmaceuticals for Women's Health Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Pharmaceuticals for Women's Health Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Pharmaceuticals for Women's Health Sales Market Share by Type (2016-2026)
Figure 68. South America Pharmaceuticals for Women's Health Sales Market Share by Application (2016-2026)
Figure 69. South America Pharmaceuticals for Women's Health Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Pharmaceuticals for Women's Health Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Pharmaceuticals for Women's Health Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa Pharmaceuticals for Women's Health Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa Pharmaceuticals for Women's Health Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa Pharmaceuticals for Women's Health Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Pharmaceuticals for Women's Health Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Pharmaceuticals for Women's Health Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE Pharmaceuticals for Women's Health Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
女性健康用医薬品の世界市場 2019年版：種類別（顆粒、丸薬、粉末、チンキ剤、錠剤、カプセル、その他）、用途別（閉経後骨粗鬆症、子宮内膜症、多嚢胞性卵巣症候群、妊娠障害、その他） Scope of the Report: The global Pharmaceuticals for Women's Health market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially …- 世界の女性医療用医薬品市場予測（～2024年）：メーカー別、地域別、種類・用途別 Women's health drug is the health drug specifically for women. Scope of the Report: The worldwide market for Women's Health Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info…
- 世界の女性健康市場 2021：企業別、地域別、種類・用途別 The Female Health market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rece…
- 世界の女性医療市場 2021：企業別、地域別、種類・用途別 The Women Healthcare market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- 世界の男性・女性脱毛市場 2021：企業別、地域別、種類・用途別 The Men and Women Hair Loss market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…